Eurofins Scientific SE (ESF0)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 83.26 |
|---|---|
| 52-week range | 55.80 – 83.26 |
| Return, 1 month / 3 months | +6.2% / +19.8% |
| Return, 1 year / 3 years | +33.5% / +87.4% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 28.9% |
| Worst drawdown (1 year) | -19.8% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eurofins Scientific is a laboratory testing company based in Luxembourg. It provides analytical testing and laboratory services in areas such as food and feed, pharmaceutical products, environmental samples, clinical diagnostics and consumer goods. Its customers include food producers, pharmaceutical companies, agricultural businesses, hospitals and government agencies, served through a network of laboratories in many countries. The company also offers related services such as genomic testing, forensic analysis and product certification.
On this site Eurofins Scientific SE appears as a stock on the XETRA Stock Exchange (Germany), code ESF0, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eurofins Scientific SE (ESF0) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 83.26 on 22 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 85 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.5% and over the last three months it rose 19.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 86 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 19.8% | ||
| 6-month return | 33.6% | ||
| 12-month return, skipping the last month | 25.7% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 28.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.8% | ||
| Liquidity | 35 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.2% |
|---|---|
| 1 month | +6.2% |
| 3 months | +19.8% |
| 6 months | +33.6% |
| 1 year | +33.5% |
| 3 years | +87.4% |
| 5 years | +46.1% |
Signals
| 50-day / 200-day average | 74.90 / 67.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.43 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | EUR 0.7200 |
| 28 Apr 2025 | EUR 0.6000 |
| 3 Jul 2024 | EUR 0.5000 |
| 4 Jul 2023 | EUR 1.0000 |
| 5 Jul 2022 | EUR 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.